Inovio Pharmaceuticals
INO
#9099
Rank
NZ$0.19 B
Marketcap
NZ$2.89
Share price
0.58%
Change (1 day)
-24.87%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): NZ-$4.80

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.82. In 2024 the company made an earnings per share (EPS) of NZ-$6.61 an increase over its 2023 EPS that were of NZ-$10.19.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.80-27.28%
2024NZ-$6.61-35.14%
2023NZ-$10.19-56.62%
2022NZ-$23.48-19.54%
2021NZ-$29.1935.9%
2020NZ-$21.48-11.57%
2019NZ-$24.2915.24%
2018NZ-$21.07-2.78%
2017NZ-$21.686.93%
2016NZ-$20.27134.88%
2015NZ-$8.63-29.51%
2014NZ-$12.24-57.34%
2013NZ-$28.70146.55%
2012NZ-$11.6420.83%
2011NZ-$9.63-29.41%
2010NZ-$13.65-48.48%
2009NZ-$26.4910%
2008NZ-$24.0911.11%
2007NZ-$21.68-41.3%
2006NZ-$36.93-66.91%
2005NZ-$111.60110.61%
2004NZ-$52.99-61.63%
2003NZ-$138.09186.67%
2002NZ-$48.17
2001N/A-100%
2000NZ-$38.54-63.64%
1999NZ-$105.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.63-486.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.31-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.27-147.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$10.91-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.22-353.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.30-230.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
NZ-$2.09-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA